Investigators reported a substantially low rate of COVID-19 vaccine uptake among individuals with Down syndrome enrolled in Tennessee Medicaid. The cohort included 438 people born 1995–2021 who met study visit criteria; 152 (35%) received at least one COVID-19 vaccine dose. Of those who initiated vaccination, 138 (91%) completed the primary series according to the authors' ascertainment. The distribution of first eligibility for COVID-19 vaccine across age bands was 95 (22%) first eligible at age 16 or older, 88 (20%) at ages 12–15, 187 (43%) at ages 5–11, and 68 (16%) at ages 6 months–4 years. These figures, drawn directly from the study, portray low coverage in a population established to be at higher risk for severe SARS‑CoV‑2 outcomes.
Short sentence: coverage was low. Longer sentence: the study team observed that, despite high clinical risk associated with Down syndrome, only about one-third of this Medicaid-enrolled cohort had received any COVID-19 vaccine by the October 1, 2024, censor date reported in the Methods and Abstract.
The authors used multivariable logistic regression to examine factors associated with receiving any COVID-19 vaccine and with completion of the primary series. Younger age at first eligibility emerged as a strong predictor of lower uptake. The study team also found that a history of nonreceipt of influenza vaccine—either never vaccinated or not vaccinated during the pandemic period—was strongly associated with both failure to receive any COVID-19 vaccine and failure to complete the primary series. Data indicated that influenza vaccine history and age were readily accessible variables that correlated with COVID-19 vaccination behavior in this cohort.
Short statement: influenza vaccination history mattered. Longer analytic sentence: because influenza vaccination records are often present in clinical and immunization registries, the investigators suggested these variables could be used to identify individuals with Down syndrome at elevated risk of remaining unvaccinated, enabling targeted outreach strategies built on existing data systems.
The study population derived from Tennessee Medicaid enrollees with Down syndrome born between 1995 and 2021. Individuals were included only if they sought care at Vanderbilt University Medical Center at least once between six months after their initial COVID-19 vaccine eligibility and October 1, 2024, per the Methods section. Vaccine administration date and vaccine type were ascertained from the Tennessee Immunization Information System, as the authors reported. Demographic and clinical characteristics used in regression models came from Medicaid enrollment and health record sources described in the abstract.
Short sentence: vaccine data were registry-based. Longer sentence: the study team applied multivariable logistic regression to estimate associations between participant characteristics—such as age strata and influenza vaccination history—and two outcomes: receipt of any COVID-19 vaccine and completion of the primary vaccine series, with all analyses constrained to the cohort and timeframe specified by the authors.
The authors confined the analytic cohort to Medicaid enrollees in Tennessee who had at least one visit to Vanderbilt University Medical Center, which limits generalizability beyond this geographic, payer, and healthcare–utilization subset. The source did not report additional details such as the specific regression covariates beyond age and influenza vaccine history in the abstract, nor did it provide subgroup counts for vaccinated versus unvaccinated by each covariate within the abstract text; those details may appear in the full text. The study period ended at October 1, 2024, and vaccine ascertainment relied on the Tennessee Immunization Information System as described.
Short sentence: selection constraints affect external validity. Longer sentence: unanswered questions that the abstract leaves open include whether socioeconomic factors, comorbidity burden, caregiver vaccination attitudes, or clinic-level outreach programs influenced uptake in this cohort—information the source did not report in the abstract and which would be relevant to designing targeted interventions.
The authors concluded that age and influenza vaccination history could identify individuals with Down syndrome at higher risk of remaining unvaccinated, enabling targeted strategies to improve coverage and reduce COVID-19-related morbidity. The paper declared no competing financial interests. The source did not report regulatory milestones or explicit next steps in the abstract; implementation details for targeted outreach were not provided in the abstract, and specifics on additional covariates used in regression models were not included in the abstract text available from PubMed.